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elevations but approaching 0 as the amplitudes decrease. We there-
fore propose a single-cell bi-parametric analysis that correlates the
rate of matrix Ca2+ extrusion with the amount of Ca2+ uptake, to
determine the impact of NCLX and Letm1. Over-expression of NCLX
revealed enhanced mitochondrial Ca2+ extrusion in cells with initial
high accumulation of Ca2+ into the matrix. On the other hand,
expression (or depletion) of Letm1 had no impact on Ca2+ extrusion,
at any level of matrix ion. Ca2+ has a dual effect on mitochondrial
redox status, stimulating Ca2+-activated dehydrogenases (reducing)
and accelerating respiration with associated enhanced formation
of reactive oxygen (oxidizing). The histamine-induced Ca2+ rise
increased the signal of the redox sensitive probe roGFP showing that
this physiological Ca2+ rise causes a net reduction of the matrix.
Enhancing Ca2+ extrusion following NCLX over-expression abolished
the Ca2+ effect. Consistent with these ﬁndings, the matrix Ca2+ rise
increased cellular NAD(P)H; an effect strongly reduced following
NCLX over-expression. Pharmacological inhibition of mitochondrial
Ca2+ extrusion, completely rescued both the reduced matrix redox
status and NAD(P)H production in NCLX-expressing cells.
We conclude that the extrusion of mitochondrial matrix Ca2+ is
mediated by NCLX but not by Letm1. By controlling the duration of
matrix Ca2+ rises, NCLX contributes to the regulation of NAD(P)H
production and modulates the mitochondrial redox state.
doi:10.1016/j.bbabio.2012.06.236
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Neuroﬁbromatosis type-1 is an autosomal dominant genetic
disorder affecting one in 2500/3500 persons worldwide. It is caused
by loss-of-function type mutations in the NF1 gene which encodes
for the protein neuroﬁbromin (Nf1) and predisposes patients to
tumor development following additional mutations on the remaining
normal allele.
Neuroﬁbromin is a large polypeptide, ubiquitously expressed,
with a functional GTPase-activating protein (GAP) domain by which
it negatively regulates the activity of the proto-oncoprotein p21-Ras.
Therefore, NF1 acts as a typical tumor suppressor gene. However, the
phenotype of NF1 patients is complex and variable, and efforts to
clearly deﬁne the molecular pathology of the disease need a complete
characterization of the biochemical functions of the Nf1 protein.
Indeed, apart from the GAP domain, the remaining 90% of neuro-
ﬁbromin is poorly characterized, and it is likely to harbour additional
domains and to be involved in other signalling pathways with an
unclear relevance for the onset and development of the NF1-
associated phenotype. Our group has previously shown that the
Ras/ERK signalling axis has a mitochondrial branch (Rasola A. et al.,
PNAS 2010), whose biological function is only partially understood.
Here we have investigated whether the hyperactivation of the Ras
signalling pathway induced by neuroﬁbromin inactivation can affect
mitochondria bioenergetics. We report that NF1−/− mouse embry-
onic ﬁbroblasts (MEFs) have a decreased Oxygen Consumption
Rate (OCR) and a lower Complex I (NADH dehydrogenase) activity
compared to wild type MEFs, suggesting that KO cells have a more
glycolytic metabolism. This metabolic switch (Warburg effect) is a
typical marker of cancer cells that favours tumor progression.
Accordingly, we observe that the absence of neuroﬁbromin confers
to MEFs the capability to form colonies in an in vitro tumorigenesis
assay, and that the use of an ERK inhibitor completely abrogates
colony formation. We hypothesize that Ras/ERK signalling is up-
stream to the regulation of mitochondrial bioenergetics, and that the
metabolic rewiring prompted by Ras/ERK activation can contribute to
the transformed phenotype that we observe in NF1−/− MEFs.
doi:10.1016/j.bbabio.2012.06.237
11P12
Abnormal HIF1 regulation of mitochondrial metabolism upon
hypoxic adaptation
L. Plecita-Hlavata, P. Jezek
Institute of Physiology, Dep.75, Academy of Sciences, Czech Republic
E-mail: plecita@biomed.cas.cz
Cell adaptation to hypoxic conditions is initiated by stabilization
of HIF1α, in coordination with reactive oxygen species (ROS) burst
originating in Complex III of respiratory chain. In principle, ROS
oxidize Fe2+ of proline hydroxylase domain enzymes and/or of
asparagine hydroxylase FIH [1], which leads to HIF1α stabilization, its
further dimerization with HIF1β in nucleus and subsequent regula-
tion of N100 proper gene expression. Canonical response leads to
suppression of mitochondrial ATP production/ oxidative phosphory-
lation in favor to glycolytic metabolism [2,3]. Such response involves
elevation of glycolytic enzymes, lactate dehydrogenases included;
and drop of mitochondrial oxygen consumption caused by inactiva-
tion of pyruvate dehydrogenase by its kinase. In contrast, we have
found that hepatocellular carcinoma HepG2 cells metabolizing glu-
tamine and galactose at aglycemia, thus preferentially providing ATP
by oxidative phosphorylation, do maintain respiration in hypoxia
(5% O2). Moreover, their respiratory chain performance runs in
optimal way, thus superoxide production extensively falls down to
~10%. This revealed phenotype is regulated in HIF-dependent manner
as HIF1α stabilization at 5 h in 5% O2 was observed with parallel ROS
burst initiating HIF pathways. Interestingly, observed morphology
changes of mitochondrial network after hypoxic adaptation were not
dependent on energy metabolism of the cell. They were pronounced
as a thinner, cobweb-like mitochondrial network, compared to atmo-
spheric conditions.
Supported by the GACR grant no. P302/10/0346 (to P.J.) and Czech
Ministry of Education grants ME09029 (to P.J.) and LH11055 (to
L.P.H.).
References
[1] E.L. Bell, T.A. Klimova, J. Eisenbart, C.T. Moraes, M.P. Murphy,
G.R. Budinger, N.S. Chandel, J. Cell Biol. 177 (2007) 1029–1036.
[2] G.L. Semenza, Cell 148 (2012) 399–408.
[3] P. Ježek, L. Plecitá-Hlavatá, K. Smolková, R. Rossignol, Int. J.
Biochem. Cell Biol. 42 (2010) 604–622.
doi:10.1016/j.bbabio.2012.06.238
11P13
Mitochondrial Nm23-H4 can switch between phosphotransfer and
lipid transfer activities
U. Schlattner1,2, A. Amoscato3, Y.Y. Tyuina3, M. Tokarska-Schlattner1,2,
S. Ramirez Rios1,2, M. Boissan5, R.F. Epand4, R.M. Epand4,
J. Klein-Seetharaman3, M.L. Lacombe5, V.E. Kagan3
Abstracts S87
